| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2000 | WO2000009752A1 Cyp3a4 nfse variant and methods of use therefor |
| 02/24/2000 | WO2000009750A1 Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression |
| 02/24/2000 | WO2000009749A1 Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof |
| 02/24/2000 | WO2000009747A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids |
| 02/24/2000 | WO2000009746A1 Vessel for blood sampling |
| 02/24/2000 | WO2000009741A1 Method of identifying proteins |
| 02/24/2000 | WO2000009737A1 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009733A1 Intracellular delivery vehicles |
| 02/24/2000 | WO2000009732A1 Electroporation buffer with cryprotective capabilities |
| 02/24/2000 | WO2000009731A1 Transgenic parasites as gene therapy agents |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009729A2 Expression of chitin synthase and chitin deacetylase genes in plants to alter the cell wall for industrial uses and improved disease resistance |
| 02/24/2000 | WO2000009728A1 Homologous recombination in plants |
| 02/24/2000 | WO2000009727A2 Dna shuffling to produce herbicide selective crops |
| 02/24/2000 | WO2000009726A1 Transgenic trees having improved nitrogen metabolism |
| 02/24/2000 | WO2000009725A2 Method for recovering proteins from the interstitial fluid of plant tissues |
| 02/24/2000 | WO2000009724A1 Transgenic plants expressing a mapkkk protein kinase domain |
| 02/24/2000 | WO2000009723A1 Maize rad6 genes and uses thereof |
| 02/24/2000 | WO2000009722A2 Methods for controlling gibberellin levels |
| 02/24/2000 | WO2000009721A1 Increasing stearate content in soybean oil by expression of acyl-acp thiosterase |
| 02/24/2000 | WO2000009720A2 Cytochrome b5 from petunia |
| 02/24/2000 | WO2000009719A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
| 02/24/2000 | WO2000009718A1 Mass secretion/expression system of true mk family protein |
| 02/24/2000 | WO2000009717A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 02/24/2000 | WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/24/2000 | WO2000009715A1 Modulation of polypeptide display on modified filamentous phage |
| 02/24/2000 | WO2000009714A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
| 02/24/2000 | WO2000009713A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | WO2000009712A1 Transcription factors regulating the expression of ethylene-inducible genes |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009710A2 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009708A1 Dna constructs comprising protease encoding sequences or inhibitors thereof |
| 02/24/2000 | WO2000009707A1 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
| 02/24/2000 | WO2000009706A2 Maize cellulose synthases and uses thereof |
| 02/24/2000 | WO2000009705A2 Selection method |
| 02/24/2000 | WO2000009704A1 Gene switch |
| 02/24/2000 | WO2000009703A1 Hiv vaccine |
| 02/24/2000 | WO2000009702A1 Cold-adapted equine influenza viruses |
| 02/24/2000 | WO2000009701A1 Pestivirus vaccination |
| 02/24/2000 | WO2000009700A1 Rna virus vector having contact infiltration capability |
| 02/24/2000 | WO2000009699A2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 02/24/2000 | WO2000009698A2 Compounds useful to affect resistance in plants and methods related thereto |
| 02/24/2000 | WO2000009697A2 Pesticidal toxins and genes from bacillus laterosporus strains |
| 02/24/2000 | WO2000009696A1 Expression of bacterial signal molecules in plants |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009694A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009692A1 Novel peptides capable of modulating inflammatory heart disease |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009689A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/24/2000 | WO2000009688A1 Novel gene and protein osbh encoded thereby |
| 02/24/2000 | WO2000009687A1 Novel gene and protein gmp30 encoded thereby |
| 02/24/2000 | WO2000009686A1 Gene |
| 02/24/2000 | WO2000009685A1 A human gene hspc011 (cblamc06) |
| 02/24/2000 | WO2000009684A1 NUCLEIC ACID CAPABLE OF BINDING SPECIFICALLY TO Ras TARGET PROTEIN |
| 02/24/2000 | WO2000009683A1 Genes for detecting bacteria and detection method by using the same |
| 02/24/2000 | WO2000009682A1 Dna shuffling of monooxygenase genes for production of industrial chemicals |
| 02/24/2000 | WO2000009681A2 CONSTRUCTION OF NORMALIZED cDNA LIBRARIES FROM EUCARYOTIC CELLS |
| 02/24/2000 | WO2000009680A1 Methods for purifying non-chromosomal nucleic acid molecules from cells |
| 02/24/2000 | WO2000009679A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009674A1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/24/2000 | WO2000009673A1 Dnazymes and methods for treating hpv-related disorders |
| 02/24/2000 | WO2000009672A1 Dnazymes and methods for treating restenosis |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009670A1 Purified human papillomavirus |
| 02/24/2000 | WO2000009669A1 Human mesencephalon cell lines and methods of use therefor |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009666A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009663A1 Enhanced uptake and transport of plant nutrients and other elements |
| 02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 02/24/2000 | WO2000009658A2 Gene regulating circadian clock function and photoperiodism |
| 02/24/2000 | WO2000009656A2 Transgenic plants expressing a dual-specificity mapk phosphatase and uses thereof |
| 02/24/2000 | WO2000009650A1 A thermal/fluidic cycling device for the purpose of nucleic acid hybridization |
| 02/24/2000 | WO2000009560A2 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009557A1 Novel gene and protein pgth encoded thereby |
| 02/24/2000 | WO2000009556A1 Human lysophospholipase gene (cbfblh05) |
| 02/24/2000 | WO2000009555A1 A human gene hspc021 (cbfaig06) |
| 02/24/2000 | WO2000009554A1 A human gene hspc018 (cbccfe10) |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009538A2 Canine growth hormone secretagogue receptor |
| 02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | WO2000009532A1 Methods and compositions for modulating transcription by use of antibodies to transcription factors |
| 02/24/2000 | WO2000009525A2 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
| 02/24/2000 | WO2000009487A1 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 02/24/2000 | WO2000009464A1 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 02/24/2000 | WO2000009205A1 Apparatus and method for the delivery of drugs and genes into tissue |
| 02/24/2000 | WO2000009159A1 Compositions of cpg and saponin adjuvants and methods thereof |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |